2024 annual financial data
Zenas BioPharma 2024 Operating margin
Direct answer
Operating margin was -3,277.76%.
Operating income was -163,888,000 USD and net income was -156,988,000 USD.
Operating cash flow was -119,674,000 USD.
Get free Zenas BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,000,000 USD
- Operating income
- -163,888,000 USD
- Net income
- -156,988,000 USD
- Operating cash flow
- -119,674,000 USD